Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Citi
Julphar
Farmers Insurance
Baxter
Moodys
Boehringer Ingelheim
Dow
Colorcon

Generated: June 17, 2018

DrugPatentWatch Database Preview

BUTORPHANOL TARTRATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Butorphanol Tartrate patents expire, and when can generic versions of Butorphanol Tartrate launch?

Butorphanol Tartrate is a drug marketed by Baxter Hlthcare Corp, Hikma Farmaceutica, Hospira, West-ward Pharms Int, Apotex Inc, and Mylan. and is included in fourteen NDAs.

The generic ingredient in BUTORPHANOL TARTRATE is butorphanol tartrate. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the butorphanol tartrate profile page.
Drug patent expirations by year for BUTORPHANOL TARTRATE
Pharmacology for BUTORPHANOL TARTRATE
Medical Subject Heading (MeSH) Categories for BUTORPHANOL TARTRATE
Synonyms for BUTORPHANOL TARTRATE
(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol
(-)-butorphanol
(-)-N-cyclobutylmethyl-3,14-dihydroxymorphinan
(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.0;{1,10}.0;{2,7}]heptadeca-2(7),3,5-triene-4,10-diol
(1S,9R,10S)-17-(CYCLOBUTYLMETHYL)-17-AZATETRACYCLO[7.5.3.0(1),(1)?.0(2),?]HEPTADECA-2(7),3,5-TRIENE-4,10-DIOL
17-(CYCLOBUTYLMETHYL)MORPHINAN-3,14-DIOL
42408-82-2
50807-69-7
58786-99-5
AN-6427
API0009093
BC 2627
BC-2627
BDBM50240437
Beforal
Beforal (TN)
BIDD:GT0549
Butorfanol
Butorfanol [INN-Spanish]
butorphanol
Butorphanol (USAN/INN)
Butorphanol [USAN:BAN:INN]
Butorphanol [USAN:INN:BAN]
Butorphanolum
Butorphanolum [INN-Latin]
C-33046
C06863
CHEBI:3242
CHEMBL33986
CTK7J9662
D03197
D0X9RG
DEA No. 9720
dl-3,14-Dihydroxy-N- morphinan
DTXSID1022714
EINECS 255-808-8
FT-0664002
GTPL7591
IFKLAQQSCNILHL-QHAWAJNXSA-N
J-504151
L-3,14-dihydroxy-N-(cyclobutylmethyl)morphinan
l-BC 2627
L-N-Cyclobutylmethyl-3,14-dihydroxymorphinan
levo-BC-2627
LS-91729
Moradol
Moradol (TN)
Morphinan-3,14-diol, 17-(cyclobutylmethyl)-
N-cyclobutylmethyl-3,14-dihydroxymorphinan
PL006230
Q-200770
QV897JC36D
SCHEMBL3749
Stadol
Stadol NS
UNII-QV897JC36D
ZINC3812988

US Patents and Regulatory Information for BUTORPHANOL TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp BUTORPHANOL TARTRATE butorphanol tartrate INJECTABLE;INJECTION 075697-001 Oct 23, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BUTORPHANOL TARTRATE PRESERVATIVE FREE butorphanol tartrate INJECTABLE;INJECTION 074620-002 Jan 22, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira BUTORPHANOL TARTRATE butorphanol tartrate INJECTABLE;INJECTION 075342-002 Nov 4, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Farmaceutica BUTORPHANOL TARTRATE butorphanol tartrate INJECTABLE;INJECTION 078400-002 May 1, 2009 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
McKinsey
Argus Health
Cipla
Merck
Accenture
Queensland Health
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.